Home | Sitemap | Search | Contact A- A A+
   
 
    Public Member Support us  
 

IBCSG 29-03 / BIG 3-98 

A survey to assess the attitude of patients aged less than 35 years, with early breast cancer, towards the risk of loss of fertility related to adjuvant therapies.

DESIGN

Design Trial 29-03

Study Chairs
Dr. Olivia Pagani - Mendrisio, Switzerland
Dr. Laura Orlando - Milano, Italy

Trial Coordinator
Susanne Roux
IBCSG Coordinating Center, Bern, Switzerland
Phone: +41 31 389 93 91
Fax: +41 31 389 93 92

Date of Activation
October 3, 2003

Date of Closure
January 28, 2008

Targeted Accrual
385 patients

Final Accrual
394 patients (IBCSG 42)


News

11.07.2014:
New publications are available  

01.06.2014:
New treatment option for young women with hormone‐sensitive breast cancer.

01.06.2014:
ASCO 2014: IBCSG plenary session on TEXT & SOFT trial results.

All News

 
  Print